Characteristic | No. (%) (n = 60) |
---|---|
Gender | |
Male | 38 (63.3) |
Female | 22 (36.7) |
Age group | |
< 6 years | 26 (43.3) |
6-11 years | 34 (56.7) |
Donor | |
MUD | 20 (33.3) |
MMFD | 27 (45.0) |
MFD | 13 (21.7) |
Primary diagnosis | |
ALL | 6 (10.0) |
ALL relapse | 11 (18.3) |
AML | 2 (3.3) |
AML relapse | 2 (3.3) |
Biphenotypic leukemia | 1 (1.7) |
CML | 2 (3.3) |
JMML | 3 (5.0) |
MDS | 5 (8.3) |
Solid tumors | 7 (11.7) |
Aplastic anemia | 9 (15.0) |
Neurometabolic diseases | 4 (6.7) |
Immunologic diseases | 6 (10.0) |
Chediak-Higashi-syndrome | 1 (1.7) |
Kostmann disease | 1 (1.7) |
Graft-versus-Host-Disease | |
Grade I | 23 (38.3) |
Grade II | 3 (5.0) |
Grade III | 4 (6.7) |
Grade IV | 2 (3.3) |
Chronic limited | 2 (3.3) |
Chronic extensive | 1 (1.7) |